These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 33788135)

  • 1. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
    Saudagar V; Patil S; Goh S; Pothiawala S
    Ir J Med Sci; 2022 Apr; 191(2):919-920. PubMed ID: 33788135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine-associated thrombocytopenia.
    Gan G; Liu H; Liang Z; Zhang G; Liu X; Ma L
    Thromb Res; 2022 Dec; 220():12-20. PubMed ID: 36265409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination.
    Jacobs JW; Booth GS; Adkins BD
    Ann Hematol; 2023 Apr; 102(4):955-959. PubMed ID: 36795118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe immune thrombocytopenia following diphtheria, tetanus, pertussis and polio vaccination in a 36-year-old Caucasian woman: a case report.
    Küster O; Schmohl J; Greiner J; Storz MA
    Eur J Med Res; 2022 May; 27(1):63. PubMed ID: 35505368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysis.
    Schaefers C; Paulsen FO; Frenzel C; Weisel K; Bokemeyer C; Seidel C
    Br J Haematol; 2023 Apr; 201(2):222-226. PubMed ID: 36793157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk of immune thrombocytopenic purpura after vaccination in children and adolescents.
    O'Leary ST; Glanz JM; McClure DL; Akhtar A; Daley MF; Nakasato C; Baxter R; Davis RL; Izurieta HS; Lieu TA; Ball R
    Pediatrics; 2012 Feb; 129(2):248-55. PubMed ID: 22232308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful Treatment of Immune Thrombocytopenic Purpura with Intracranial Hemorrhaging and Duodenal Bleeding Following SARS-CoV-2 Vaccination.
    Baba Y; Sakai H; Kabasawa N; Harada H
    Intern Med; 2022 Jun; 61(12):1891-1895. PubMed ID: 35400701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
    Saluja P; Gautam N; Yadala S; Venkata AN
    Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine.
    Sivaramakrishnan P; Mishra M
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35354570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Kim G; Choi EJ; Park HS; Lee JH; Lee JH; Lee KH
    J Korean Med Sci; 2021 Nov; 36(43):e306. PubMed ID: 34751013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe immune thrombocytopenia following COVID-19 vaccination (Moderna) and immune checkpoint inhibitor.
    Chong KM; Yang CY; Lin CC; Lien WC
    Am J Emerg Med; 2022 Jun; 56():395.e1-395.e3. PubMed ID: 35339338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature.
    Owatanapanich S; Wanlapakorn N; Tangsiri R; Poovorawan Y
    Southeast Asian J Trop Med Public Health; 2014 Sep; 45(5):1053-7. PubMed ID: 25417506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine administration and the development of immune thrombocytopenic purpura in children.
    Cecinati V; Principi N; Brescia L; Giordano P; Esposito S
    Hum Vaccin Immunother; 2013 May; 9(5):1158-62. PubMed ID: 23324619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.
    Bidari A; Asgarian S; Pour Mohammad A; Naderi D; Anaraki SR; Gholizadeh Mesgarha M; Naderkhani M
    Eur J Haematol; 2023 Apr; 110(4):335-353. PubMed ID: 36562217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.
    Perez-Vilar S; Weibel D; Sturkenboom M; Black S; Maure C; Castro JL; Bravo-Alcántara P; Dodd CN; Romio SA; de Ridder M; Nakato S; Molina-León HF; Elango V; Zuber PLF;
    Vaccine; 2018 Jan; 36(3):347-354. PubMed ID: 28558983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS).
    Welsh KJ; Baumblatt J; Chege W; Goud R; Nair N
    Vaccine; 2021 Jun; 39(25):3329-3332. PubMed ID: 34006408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.
    Farrington P; Pugh S; Colville A; Flower A; Nash J; Morgan-Capner P; Rush M; Miller E
    Lancet; 1995 Mar; 345(8949):567-9. PubMed ID: 7619183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
    Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
    Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32 Years of passive surveillance data.
    Jacobs JW; Booth GS; Guarente J; Schlafer D; Zheng L; Adkins BD
    Br J Haematol; 2023 Apr; 201(2):227-233. PubMed ID: 36564040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenic purpura after measles-mumps-rubella vaccination: a systematic review of the literature and guidance for management.
    Mantadakis E; Farmaki E; Buchanan GR
    J Pediatr; 2010 Apr; 156(4):623-8. PubMed ID: 20097358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.